Oticon Medical Reports the US FDA’s Clearance of its Bone Conduction Hearing System
Shots:
- The US FDA has granted clearance to the transcutaneous bone conduction hearing system, Sentio System, intended for subjects (≥12yrs.) with conductive hearing loss, mixed hearing loss, or single-sided deafness
- The device comprises an external sound processor, Sentio 1 Mini, and an implant placed under the skin, Sentio Ti Implant
- Sentio 1 Mini provides 360-degree sound and 9.5kHz bandwidth while the Sentio Ti implant, intended for progressive hearing loss, is developed to handle powerful sound processors for higher maximum force output
Ref: Oticon Medical | Image: Oticon Medical
Related News:- Orthofix Medical Reports the US FDA’s Clearance of Fitbone Transport and Lengthening System
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
